Immunology of intraocular tumors

Jerry Y. Niederkorn, Shixuan Wang

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The immune surveillance hypothesis was introduced over 30 years ago and proposed that neoplasms express novel antigens that subjected them to immune detection and elimination. In order for immune surveillance to be effective in controlling neoplasms, two requirements must be satisfied: 1) the tumor must arise in a body site that permits the induction of the full array of immune responses and 2) the immune elements generated must have unfettered access to the tumor and be able to express their entire range of effector functions at the tumor site. The unique immunologic and anatomic features of the eye prevent the induction and expression of conventional immunity-a phenomenon known as 'immune privilege.' Although ocular immune privilege represents a theoretical obstacle to immune surveillance, some highly immunogenic intraocular tumors can circumvent immune privilege and undergo immune rejection. Uveal melanoma is the most common intraocular malignancy in adults, yet it occurs with a frequency that is no higher than neoplasms arising in conventional body sites. The presence of either tumor-infiltrating lymphocytes (TIL) or tumor-infiltrating macrophages (TIM) is associated with a poor prognosis in uveal melanoma patients and suggests that some immune responses to intraocular tumors might exacerbate, rather than mitigate, tumor progression. Although counterintuitive, this proposition is consistent with the 'immune stimulation' hypothesis of tumor progression offered by Richmond Prehn over thirty years ago. It remains to be ascertained if immune stimulation affects the malignancy of ocular tumors, but it represents an intriguing explanation for the paradoxes of uveal melanoma.

Original languageEnglish (US)
Pages (from-to)105-110
Number of pages6
JournalOcular Immunology and Inflammation
Volume13
Issue number1
DOIs
StatePublished - Feb 2005

Fingerprint

Allergy and Immunology
Neoplasms
Tumor-Infiltrating Lymphocytes
Immunity
Macrophages

Keywords

  • Immune privilege
  • Immunology
  • Natural killer cells
  • Tumor
  • Uveal melanoma

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy

Cite this

Immunology of intraocular tumors. / Niederkorn, Jerry Y.; Wang, Shixuan.

In: Ocular Immunology and Inflammation, Vol. 13, No. 1, 02.2005, p. 105-110.

Research output: Contribution to journalArticle

Niederkorn, Jerry Y. ; Wang, Shixuan. / Immunology of intraocular tumors. In: Ocular Immunology and Inflammation. 2005 ; Vol. 13, No. 1. pp. 105-110.
@article{5b18572f97b445e489099ce95573587b,
title = "Immunology of intraocular tumors",
abstract = "The immune surveillance hypothesis was introduced over 30 years ago and proposed that neoplasms express novel antigens that subjected them to immune detection and elimination. In order for immune surveillance to be effective in controlling neoplasms, two requirements must be satisfied: 1) the tumor must arise in a body site that permits the induction of the full array of immune responses and 2) the immune elements generated must have unfettered access to the tumor and be able to express their entire range of effector functions at the tumor site. The unique immunologic and anatomic features of the eye prevent the induction and expression of conventional immunity-a phenomenon known as 'immune privilege.' Although ocular immune privilege represents a theoretical obstacle to immune surveillance, some highly immunogenic intraocular tumors can circumvent immune privilege and undergo immune rejection. Uveal melanoma is the most common intraocular malignancy in adults, yet it occurs with a frequency that is no higher than neoplasms arising in conventional body sites. The presence of either tumor-infiltrating lymphocytes (TIL) or tumor-infiltrating macrophages (TIM) is associated with a poor prognosis in uveal melanoma patients and suggests that some immune responses to intraocular tumors might exacerbate, rather than mitigate, tumor progression. Although counterintuitive, this proposition is consistent with the 'immune stimulation' hypothesis of tumor progression offered by Richmond Prehn over thirty years ago. It remains to be ascertained if immune stimulation affects the malignancy of ocular tumors, but it represents an intriguing explanation for the paradoxes of uveal melanoma.",
keywords = "Immune privilege, Immunology, Natural killer cells, Tumor, Uveal melanoma",
author = "Niederkorn, {Jerry Y.} and Shixuan Wang",
year = "2005",
month = "2",
doi = "10.1080/09273940490518586",
language = "English (US)",
volume = "13",
pages = "105--110",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Immunology of intraocular tumors

AU - Niederkorn, Jerry Y.

AU - Wang, Shixuan

PY - 2005/2

Y1 - 2005/2

N2 - The immune surveillance hypothesis was introduced over 30 years ago and proposed that neoplasms express novel antigens that subjected them to immune detection and elimination. In order for immune surveillance to be effective in controlling neoplasms, two requirements must be satisfied: 1) the tumor must arise in a body site that permits the induction of the full array of immune responses and 2) the immune elements generated must have unfettered access to the tumor and be able to express their entire range of effector functions at the tumor site. The unique immunologic and anatomic features of the eye prevent the induction and expression of conventional immunity-a phenomenon known as 'immune privilege.' Although ocular immune privilege represents a theoretical obstacle to immune surveillance, some highly immunogenic intraocular tumors can circumvent immune privilege and undergo immune rejection. Uveal melanoma is the most common intraocular malignancy in adults, yet it occurs with a frequency that is no higher than neoplasms arising in conventional body sites. The presence of either tumor-infiltrating lymphocytes (TIL) or tumor-infiltrating macrophages (TIM) is associated with a poor prognosis in uveal melanoma patients and suggests that some immune responses to intraocular tumors might exacerbate, rather than mitigate, tumor progression. Although counterintuitive, this proposition is consistent with the 'immune stimulation' hypothesis of tumor progression offered by Richmond Prehn over thirty years ago. It remains to be ascertained if immune stimulation affects the malignancy of ocular tumors, but it represents an intriguing explanation for the paradoxes of uveal melanoma.

AB - The immune surveillance hypothesis was introduced over 30 years ago and proposed that neoplasms express novel antigens that subjected them to immune detection and elimination. In order for immune surveillance to be effective in controlling neoplasms, two requirements must be satisfied: 1) the tumor must arise in a body site that permits the induction of the full array of immune responses and 2) the immune elements generated must have unfettered access to the tumor and be able to express their entire range of effector functions at the tumor site. The unique immunologic and anatomic features of the eye prevent the induction and expression of conventional immunity-a phenomenon known as 'immune privilege.' Although ocular immune privilege represents a theoretical obstacle to immune surveillance, some highly immunogenic intraocular tumors can circumvent immune privilege and undergo immune rejection. Uveal melanoma is the most common intraocular malignancy in adults, yet it occurs with a frequency that is no higher than neoplasms arising in conventional body sites. The presence of either tumor-infiltrating lymphocytes (TIL) or tumor-infiltrating macrophages (TIM) is associated with a poor prognosis in uveal melanoma patients and suggests that some immune responses to intraocular tumors might exacerbate, rather than mitigate, tumor progression. Although counterintuitive, this proposition is consistent with the 'immune stimulation' hypothesis of tumor progression offered by Richmond Prehn over thirty years ago. It remains to be ascertained if immune stimulation affects the malignancy of ocular tumors, but it represents an intriguing explanation for the paradoxes of uveal melanoma.

KW - Immune privilege

KW - Immunology

KW - Natural killer cells

KW - Tumor

KW - Uveal melanoma

UR - http://www.scopus.com/inward/record.url?scp=17844389598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844389598&partnerID=8YFLogxK

U2 - 10.1080/09273940490518586

DO - 10.1080/09273940490518586

M3 - Article

C2 - 15835077

AN - SCOPUS:17844389598

VL - 13

SP - 105

EP - 110

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 1

ER -